Sienna Biopharmaceuticals, Inc. Total Liabilities
Sienna Biopharmaceuticals, Inc. had Total Liabilities of $20.39 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2019-11-12
- 2019-09-30: Liabilities $20.39M.
- 2019-06-30: Liabilities $80.64M.
- 2019-03-31: Liabilities $81.77M.
- 2018-12-31: Liabilities $80.72M.
| Period end | Liabilities |
|---|---|
| 2019-09-30 | $20.39M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $80.64M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $81.77M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $80.72M 10-Q · filed 2019-11-12 |
| 2018-09-30 | $79.70M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $80.19M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $47.12M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $45.65M 10-K · filed 2019-03-14 |
| 2017-09-30 | $53.05M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $48.00M 10-Q · filed 2017-09-07 |
| 2016-12-31 | $40.26M 10-K · filed 2018-03-15 |